A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- NJACTS Community Engagement Core Available Services
- New Jersey Becomes a Rising Regional Hub for Abortion Care.
- Rutgers Startup Seeks to Stop Chronic Diseases Before They Begin.
- How GLP-1s Are Shifting the Story of Weight, Wellness and Self-Acceptance.
- Scientists Develop New Gut Health Measure That Tracks Disease.
Categories
- Community (2,485)
- Covid (999)
- CTO Events (6)
- News (3,150)
- Pilots (21)